Influenza Vaccine and Reimbursement Guidelines for 2020-2021 for Medicaid and NC Health Choice

<p>NC Immunization Program/Vaccines for Children (NCIP/VFC),&nbsp;Billing/Reporting Influenza Vaccines for Medicaid Beneficiaries,&nbsp;Borrowing and Replacement of VFC and Private Vaccines,&nbsp;Borrowing and Replacement of VFC and Private Vaccines,&nbsp;Billing/Reporting Influenza Vaccines for NC Health Choice Beneficiaries,&nbsp;Immunization Billing for Medicaid and NC Health Choice Beneficiaries from FQHCs and RHCs and&nbsp;NDC&rsquo;s Change Each Year for Influenza Vaccines.&nbsp;&nbsp;</p>

For 2020-2021, trivalent (three-component) egg-based vaccines are recommended to contain:

  • A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus (updated)
  • A/Hong Kong/2671/2019 (H3N2)-like virus (updated)
  • B/Washington/02/2019 (B/Victoria lineage)-like virus (updated)

Quadrivalent (four-component) egg-based vaccines, which protect against a second lineage of B viruses, are recommended to contain:

  • the three recommended viruses above, plus B/Phuket/3073/2013-like (Yamagata lineage) virus.

For 2020-2021, cell- or recombinant-based vaccines are recommended to contain:

  • A/Hawaii/70/2019 (H1N1)pdm09-like virus (updated)
  • A/Hong Kong/45/2019 (H3N2)-like virus (updated)
  • B/Washington/02/2019 (B/Victoria lineage)-like virus (updated)
  • B/Phuket/3073/2013-like (Yamagata lineage) virus

For further details on the 2020-2021 influenza vaccine, visit the Centers for Disease Control (CDC) Flu Season web page. 

NC Immunization Program/Vaccines for Children (NCIP/VFC) 

Under NC Immunization Program/Vaccines for Children (NCIP/VFC) guidelines, the NC Division of Public Health (DPH) Immunization Branch distributes all childhood vaccines that are recommended by the Advisory Committee on Immunization Practices (ACIP) to local health departments, Federally Qualified Health Centers (FQHC), Rural Health Clinics (RHC), hospitals and private providers. 

For the 2020-2021 influenza season, NCIP/VFC influenza vaccine – all quadrivalent – is available at no charge to providers for children 6 months through 18 years of age who are eligible for the VFC program, according to the NCIP coverage criteria. The current NCIP coverage criteria and definitions of VFC categories can be found on DPH’s Immunization Branch web page. 

For providers interested in enrolling in the VFC program, information can be found on the CDC information page and the NC DPH website.   

Eligible VFC children include Medicaid beneficiaries and NC Health Choice beneficiaries who are American Indian and Alaska Native (AI/AN). These beneficiaries can be identified as AI/AN in one of two ways: 

  1. They are either identified as MIC-A and MIC-S on their NC Health Choice Identification Cards or, 
  2. Beneficiaries/parents may self-declare their VFC eligibility status according to NCIP/VFC program policy. 

When NC Health Choice beneficiaries self-declare their status as AI/AN, and the provider administers the state-supplied vaccine, the provider must report the CPT vaccine code with $0.00 and may bill NC Health Choice for the administration costs only. For further details, refer to the June 2012 Medicaid Bulletin article Billing for Immunizations for American Indian and Alaska Native NC Health Choice Recipients.  

All other NC Health Choice beneficiaries are considered insured (not VFC eligible) and must be administered privately purchased vaccines. 

For VFC/NCIP vaccines administered to VFC-eligible children, providers must report only the vaccine code(s) with $0.00. Providers may bill NC Medicaid for the administration fee for Medicaid and eligible AI/AN NC Health Choice beneficiaries. 

Providers who administer privately purchased vaccines to VFC eligible beneficiaries will not be reimbursed for the vaccine and cannot bill the beneficiary for that cost. Only the administration fee(s) will be reimbursed.  

Providers must purchase vaccines for children who are not VFC-eligible (including all NC Health Choice children who are not AI/AN) and adult patients. For Medicaid-eligible beneficiaries age 19 years and older, purchased vaccine and administration costs may be billed to NC Medicaid, according to the guidelines stated in Tables 2 and 3 below. To determine who is eligible for NCIP influenza and other vaccines, visit DPH’s Immunization Branch web page. 

Billing/Reporting Influenza Vaccines for Medicaid Beneficiaries 

The following tables indicate the vaccine codes that may be either reported (with $0.00 billed) or billed (with the usual and customary charge) for influenza vaccine, depending on the age of the beneficiaries and the formulation of the vaccine. The tables also indicate the administration codes that may be billed, depending on the age of the beneficiaries and the vaccine(s) administered to them.

Note: The information in the following tables is not detailed billing guidance. Specific information on billing all immunization administration codes for Health Check beneficiaries can be found in the Health Check Billing Guide. 

Borrowing and Replacement of VFC and Private Vaccines

For the 2020-2021 flu season only, providers will be allowed to use the two-way borrowing policy with seasonal flu vaccine in order to prevent missed opportunities for both VFC-eligible and fully insured children. Under this policy, providers may use the VFC vaccine to vaccinate insured children or privately purchased vaccine to vaccinate VFC-eligible children in the event there is a delay in shipment of either stock. The amount of flu vaccine that can be borrowed is not limited to a certain amount; however, as with other VFC vaccine products, the borrowing policy does not alleviate a provider’s responsibility to appropriately order, in a timely manner, enough private flu vaccine to vaccinate insured children within the practice.

Please note that all doses to be replaced must be documented on the NCIP borrowing and replacement report form every time borrowing occurs. When borrowing occurs, doses should be replaced with the same product type. The brand does not have to be replaced with the same brand if the products have the same administration indications. The NCIP borrowing report required by the CDC is located on the NCIP website at: http://bit.ly/BorrowingForm.

CDC has released Interim Guidance for Immunization Services During the COVID-19 Pandemic. This guidance is intended to help immunization providers in a variety of clinical and alternative settings with the safe administration of vaccines during the COVID-19 pandemic.

If you have any questions or need assistance, please contact the Immunization Branch Help Desk at 1-877-873-6247 and press option 6.

Table 1: Influenza Billing Codes for Medicaid Beneficiaries Less Than 19 Years of Age Who Receive VFC Influenza Vaccine. These codes are reported with $0.00.

Vaccine CPT Codes to Report

Vaccine CPT Code to Report

NDC covered by VFC Program

CPT Code Description

90672

66019-0307-10

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

70461-0320-03

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use

90685

33332-0220-20

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative-free, 0.25 mL dosage, for intramuscular use

90686

19515-0816-52 33332-0320-01

49281-0420-10

49281-0420-50

58160-0885-52

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90687

49281-0633-15

Influenza virus vaccine, quadrivalent (IIV4), split virus, NOT preservative free, 0.25 mL dosage, for intramuscular use

90688

49281-0633-15

Influenza virus vaccine, quadrivalent (IIV4), split virus, NOT preservative free, 0.5 mL dosage, for intramuscular use

 

 

 

 

 

 

 

 

 

 

Administrative CPT Codes to Bill

Administration CPT Code(s) to Bill

CPT Code Description

90471EP

Immunization administration (includes percutaneous, intradermal, subcutaneous or intramuscular injections); one vaccine (single or combination vaccine/toxoid)

+90472EP (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure).

90460EP

Immunization administration through 18 years via any route of administration, with counseling by physician or other qualified health care professional.

90473EP

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

 

 

 

 

 

 

 

 

 

*90472 will only be used if another vaccine is given in addition to the flu vaccine. Providers may bill more than one unit of 90472 as appropriate.

 

Table 2: Influenza Billing Codes for Medicaid Beneficiaries 19 to 21 Years of Age

Use the following codes to bill Medicaid for an influenza vaccine purchased and administered to beneficiaries aged 19-21 years. 

Note: The VFC/NCIP provides influenza products for recipients aged 6 months through 18 years only. The VFC/NCIP will NOT provide influenza vaccine for recipients 19 years and older. 

Vaccine CPT Codes to Report

Vaccine CPT Code to Report

CPT Code Description

90672

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use

90682

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688

Influenza virus vaccine, quadrivalent (IIV4), split virus, NOT preservative free, 0.5 mL dosage, for intramuscular use

90756

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use

Administrative CPT Codes to Report

Administrative CPT Code(s) to Report

CPT Code Description

90471EP

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid)

+90472EP (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure).

90473EP

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

*90472 will only be used if another vaccine is given in addition to the flu vaccine. Providers may bill more than one unit of 90472 as appropriate.

Table 3: Influenza Billing Codes for Medicaid Beneficiaries 21 Years of Age and Older

Use the following codes to bill Medicaid for influenza vaccine purchased and administered to beneficiaries 21 years of age and older. 

Note: The VFC/NCIP provided influenza products for VFC-age (6 months through 18 years of age) beneficiaries only. The VFC/NCIP will not provide influenza vaccine for beneficiaries 19 years and older. 

Vaccine CPT Code to Report

Vaccine CPT Code to Report

CPT Code Description

90653

Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use

90662

Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90672

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5mL dosage, for intramuscular use

90682

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688

Influenza virus vaccine, quadrivalent (IIV4), split virus, NOT preservative free, 0.5 mL dosage, for intramuscular use

90694

Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use

90756

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use:

Administrative CPT Code(s) to Bill

Administrative CPT Code(s) to Bill

CPT Code Description

90471

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid)

+90472 (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure)

90473EP

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

*90472 will only be used if another vaccine is given in addition to the flu vaccine. Providers may bill more than one unit of 90472 as appropriate.

For beneficiaries 21 years or older receiving an influenza vaccine, an evaluation and management (E/M) code cannot be reimbursed to any provider on the same day that injection administration fee codes (e.g., 90471 or 90471 and +90472) are reimbursed, unless the provider bills an E/M code for a separately identifiable service by appending modifier 25 to the E/M code. 

Billing/Reporting Influenza Vaccines for NC Health Choice Beneficiaries 

The following table indicates the vaccine codes that may be either reported (with $0.00) or billed (with the usual and customary charge) for influenza vaccine, depending on an NC Health Choice beneficiary’s VFC eligibility (that is, if the beneficiary is AI/AN) and the formulation of the vaccine. The table also indicates the administration codes that may be billed.

Table 4: Influenza Billing Codes for NCHC Beneficiaries 6 Years through 18 Years of Age Who Receive VFC Vaccine (MIC-A and MIC-S Eligibility Categories or Beneficiaries in Other Categories who Self-Declare AI/AN Status) or Purchased Vaccine (All Other NC Health Choice Eligibility Categories)

Vaccine CPT Code to Report

Vaccine CPT Code to Report

CPT Code Description

90672

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use

90682

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688

Influenza virus vaccine, quadrivalent (IIV4), split virus, NOT preservative free, 0.5 mL dosage, for intramuscular use

90756

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use:

Administrative CPT Code(s) to Bill

Administrative CPT Code(s) to Bill

CPT Code Description

90471TJ

Immunization administration (includes percutaneous, intradermal, subcutaneous or intramuscular injections); one vaccine (single or combination vaccine/toxoid)

+90472TJ (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous or intramuscular injections); each additional vaccine (single and combination vaccine/toxoid) (List separately in addition to code for primary procedure).

90460TJ

Immunization administration through 18 years via any route of administration, with counseling by physician or other qualified health care professional.

90473TJ

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

*90472 will only be used if another vaccine is given in addition to the flu vaccine. Providers may bill more than one unit of 90472 as appropriate 

Notes 

  • The EP modifier should not be billed on NC Health Choice claims. The TJ modifier should be used. 
  • There is no co-pay for office visits and wellness checks. 

Immunization Billing for Medicaid and NC Health Choice Beneficiaries from FQHCs and RHCs 

For beneficiaries 0 through 20 years of age 

If vaccines are provided through the NCIP/VFC, the center/clinic shall report the CPT vaccine codes (with $0.00 billed) under Physician Services NPI and may bill for the administration codes (CPT procedure codes 90471EP through 90472EP OR 90460EP). This billing is appropriate when only vaccines are provided at the visit, or if vaccines were provided in conjunction with a wellness check. If a core visit was billed, CPT vaccine codes shall be reported (with $0.00 billed) under Physician Services NPI and an administration code shall not be billed. 

If purchased vaccines (non-VFC eligible) were administered, the center/clinic may bill the CPT vaccine codes (with their usual and customary charge) under the Physician Services NPI for the vaccines administered and may bill for the administration codes (with the usual and customary charge). This billing is appropriate if only vaccines were given at the visit or if vaccines were given in conjunction with a wellness check. If a core visit was billed, CPT vaccine codes shall be reported (with $0.00 billed) under the Physician Services NPI provider number and the administration codes shall not be billed. For detailed billing guidance, refer to the Health Check Billing Guide. 

For beneficiaries 21 years of age and older 

When purchased vaccines are administered, CPT vaccine codes may be billed (with the usual and customary charge) and administration codes may be billed (with the usual and customary charge) under the Physician Services NPI. This is applicable when vaccine administration was the only service provided that visit. When a core visit is billed, the CPT vaccine code shall be reported (with $0.00 billed) under the Physician Services NPI and an immunization administration code may not be billed. 

For influenza vaccine and administration fee rates, refer to the Physician’s Drug Program fee schedule on DHB’s Fee Schedule web page and Physician Services Fee Schedule web page. 

Immunization Billing for Medicaid Beneficiaries from Immunizing Pharmacies

For beneficiaries 21 years of age and older 

Effective Jan. 1, 2016, NC Medicaid will reimburse pharmacies for covered vaccines, including influenza vaccines, as permitted by G.S. 90-85.15B (see below) when administered to NC Medicaid beneficiaries 19 years of age and older by an immunizing pharmacist. 

Table 5: Billing Codes to be used by Pharmacist for Medicaid Beneficiaries 19 Years of Age or Older

Vaccine CPT Code to Report

CPT Code Description

90653CG

Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use

90662CG

Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use

90672CG

Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use

90674CG

influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5mL dosage, for intramuscular use

90682CG

Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use

90686CG

Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use

90688CG

Influenza virus vaccine, quadrivalent (IIV4), split virus, NOT preservative free, 0.5 mL dosage, for intramuscular use

90694CG

Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use

90756CG

Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*The CG modifier must be appended to every vaccine and vaccine administration CPT code used to bill vaccines by pharmacists. The CG modifier identifies a Pharmacy Provider in NCTracks for vaccine claims billing purposes.  

Billing Codes to be used by Pharmacists for Medicaid Beneficiaries 19 Years of Age and Older

CPT Code(s)

CPT Code Description

90471CG

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); one vaccine (single or combination vaccine/toxoid)

90472CG (add-on code)*

Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine. (Separately list the add-on code(s) for each additional single vaccine and/or combination vaccine/toxoid administered, in addition to the primary procedure)

90473CG

Immunization administration by intranasal or oral route; 1 vaccine (single or combination vaccine/toxoid). Do not report 90473 in conjunction with 90471.

The CG modifier must be appended to every vaccine and vaccine administration CPT code used to bill vaccines by pharmacists. The CG modifier identifies a Pharmacy Provider in NCTracks for vaccine claims billing purposes.  

*Providers may bill more than one unit of 90472 as appropriate.

Detailed information about the regulations regarding pharmacist immunization can be found at Pharmacist Administrated Vaccine and Reimbursement Guidelines published in the October 2016 Medicaid Bulletin. Please note that NDCs are required on vaccine claims. 

NDC’s Change Each Year for Influenza Vaccines

Providers are required to use appropriate NDCs that correspond to the vaccine used for administration and corresponding CPT code. Note that not all products and NDCs under their respective CPT codes will be covered.  

Influenza vaccines are licensed each year with new NDCs, so it is important to report the correct code for the products you are using to avoid having claims deny with edit 00996 (Mismatched NDC) which will require the claim to be resubmitted with the correct NDC. Below are the influenza vaccine procedure (CPT) codes and corresponding NDCs that should be used for the 2020-2021 influenza season:

CPT and NDC codes for the 2020-2021 Influenza Vaccine Products

CPT Codes

NDC codes

90653

Fluad: 70461-0020-03, 70461-0020-04

90662

Fluzone High-Dose: 49281-0120-65, 49281-0120-88

90672

FluMist Quadrivalent: 66019-0307-01, 66019-0307-10

90674

Flucelvax Quadrivalent: 70461-0320-03, 70461-0320-04

90682

Flublok Quadrivalent: 49281-0720-10, 49281-0720-88

90685

Afluria Quadrivalent: 33332-0220-20, 33332-0220-21

90686

Afluria Quadrivalent: 33332-0320-01, 33332-0320-02

Fluarix Quadrivalent: 58160-0885-41, 58160-0885-52

FluLaval Quadrivalent: 19515-0816-41, 19515-0816-52

Fluzone Quadrivalent syringe: 49281-0420-50, 49281-0420-88

Fluzone Quadrivalent vial:  49281-0420-10, 49281-0420-58

90687

Afluria Quadrivalent: 33332-0420-10, 33332-0420-11

Fluzone Quadrivalent: 49281-0633-15, 49281-0633-78

90688

Afluria Quadrivalent: 33332-0420-10, 33332-0420-11

Fluzone Quadrivalent: 49281-0633-15, 49281-0633-78

90694

Fluad Quad: 70461-0120-03, 70461-0120-04

90756

Flucelvax Quadrivalent: 70461-0420-10, 70461-0420-11

Contact

GDIT, 1-800-688-6696
 

Related Topics: